VERIFIEDEconomic Times News·23 Jul 2026negative

Dr Reddy’s shares crack 9% after weak Q1; these 3 brokerages slash their target prices

AI Summary

·Dr Reddy's shares fell 9% following a weak Q1 FY27 performance.
·Net profit decreased by 69% year-on-year to Rs 443 crore, and revenue declined 6% to Rs 8,071 crore.
·A Rs 240 crore semaglutide API-related impact and increased costs affected earnings.